Core--Clinical evaluation

核心--临床评价

基本信息

项目摘要

The Clinical Evaluation Core's goals are to: (1) recruit, characterize, and follow all human subjects participating in projects #2-7 of the CCNMD (2) develop and maintain state-of-the-art methods for clinical characterization of human framework for testing the stress-diathesis model of suicidal behavior. The CEC identified and recruits patients with MDE, BPD, and Schizophrenia across the life cycle (and post-mortem). Normal volunteers are recruited to provide normative values on the clinical and neurobiological measures used and to establish psychometric properties of measures in a non-pathological population. The CEC utilizes a core of clinical/neuropsychological instruments covering major risk factor domains for suicidal behavior, and ensures uniformity of assessment domains and measures across the projects of the CCNMD. These assessments include Axis I and II diagnostic interviews, measures of state and trait-related risk factors, neuropsychological assessment, measures of suicidal behavior, demographic history, life events, social functioning, family psychiatric history. Assessments are performed at intake, at time of biological procedures, at discharge, at 3 month, 1 and 2 year follow-up. The CEC investigates, develops and tests new assessment procedures to address current and future needs in the field of suicide research, and regularly reviews the reliability and validity of instruments. The CEC ensures the quality of clinical assessments through inter-rater reliability rounds using live or taped interviews. On all measures, our faculty provides consultation to investigators in research methodology and result interpretation. The CEC faculty provides consultation to investigators in research methodology and result interpretation. The CEC has successfully recruited and followed adequate members of life subjects in the proposed diagnostic and age categories. The training and reliability of all CCNMD raters is coordinated by the CEC. The CEC works with SCC staff in developing forms, data management procedures and in generating reliability statistics The CEC coordinates with the BIC regarding recruitment, interviewing, control matching and subject flow. The CEC obtains the blood and cerebrospinal fluid from subjects to be analyzed by the CLC. The CEC interfaces with the Administrative Core regarding recruitment of new staff and maintenance of a central database of all CEC manuscripts. The CEC coordinates all diagnostic consensus conferences.
临床评价核心的目标是:(1)招募、表征和 跟踪参与CCNMD项目#2-7的所有人类受试者 (2)开发和维护最先进的临床方法, 人体应激素质测试框架的表征 自杀行为的模式。CEC确定并招募了以下患者: MDE,BPD和精神分裂症在整个生命周期(和死后)。 招募正常志愿者以提供关于 使用临床和神经生物学测量,并建立心理测量 在非病理人群中的测量的性质。CEC利用 涵盖主要风险的临床/神经心理学工具核心 自杀行为的因素域,并确保一致性, CCNMD项目的评估领域和措施。 这些评估包括轴I和轴II诊断性访谈、测量 状态和特质相关的风险因素,神经心理学评估, 自杀行为、人口统计学史、生活事件、社会 功能正常家族精神病史评估在 摄入、生物程序时、出院时、3个月、1个月和2个月 年的后续。CEC调查、开发和测试新的评估 解决自杀领域当前和未来需求的程序 研究,并定期审查工具的可靠性和有效性。 CEC通过评估者间评估确保临床评估的质量 可靠性轮使用现场或录音采访。从各个方面来看, 教师为研究人员提供研究方法方面的咨询 和结果解释。CEC教师提供咨询, 研究方法和结果解释。中央选举委员会 已经成功地招募并跟踪了足够的生命主体成员, 在诊断和年龄分类中。训练和可靠性 所有CCNMD评分员的评分由CEC协调。CEC与 SCC工作人员制定表格、数据管理程序, 生成可靠性统计信息CEC与BIC协调 关于招聘、面试、控制匹配和主题流程。 CEC从受试者获得血液和脑脊液, CLC分析。CEC与行政核心接口 关于征聘新工作人员和维持一个中央数据库 所有的CEC手稿。CEC协调所有诊断共识 两会

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HAROLD A. SACKEIM其他文献

HAROLD A. SACKEIM的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HAROLD A. SACKEIM', 18)}}的其他基金

OPTIMIZATION OF ELECTROCONVULSIVE THERAPY
电休克治疗的优化
  • 批准号:
    6629282
  • 财政年份:
    2001
  • 资助金额:
    $ 17.72万
  • 项目类别:
Core--Clinical evaluation
核心--临床评价
  • 批准号:
    6480789
  • 财政年份:
    2001
  • 资助金额:
    $ 17.72万
  • 项目类别:
OPTIMIZATION OF ELECTROCONVULSIVE THERAPY
电休克治疗的优化
  • 批准号:
    6260485
  • 财政年份:
    2001
  • 资助金额:
    $ 17.72万
  • 项目类别:
OPTIMIZATION OF ELECTROCONVULSIVE THERAPY
电休克治疗的优化
  • 批准号:
    6691744
  • 财政年份:
    2001
  • 资助金额:
    $ 17.72万
  • 项目类别:
OPTIMIZATION OF ELECTROCONVULSIVE THERAPY
电休克治疗的优化
  • 批准号:
    6841642
  • 财政年份:
    2001
  • 资助金额:
    $ 17.72万
  • 项目类别:
OPTIMIZATION OF ELECTROCONVULSIVE THERAPY
电休克治疗的优化
  • 批准号:
    6499375
  • 财政年份:
    2001
  • 资助金额:
    $ 17.72万
  • 项目类别:
Core--Clinical evaluation
核心--临床评价
  • 批准号:
    6339877
  • 财政年份:
    2000
  • 资助金额:
    $ 17.72万
  • 项目类别:
CEREBROVASCULAR ABNORMALITIES IN LATE ONSET DEPRESSION
迟发性抑郁症的脑血管异常
  • 批准号:
    6343721
  • 财政年份:
    1997
  • 资助金额:
    $ 17.72万
  • 项目类别:
CEREBROVASCULAR ABNORMALITIES IN LATE ONSET DEPRESSION
迟发性抑郁症的脑血管异常
  • 批准号:
    2034705
  • 财政年份:
    1997
  • 资助金额:
    $ 17.72万
  • 项目类别:
CONTINUATION PHARMACOTHERAPY FOLLOWING ECT
ECT 后继续药物治疗
  • 批准号:
    2890927
  • 财政年份:
    1997
  • 资助金额:
    $ 17.72万
  • 项目类别:

相似海外基金

FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
  • 批准号:
    EP/Y036395/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.72万
  • 项目类别:
    Research Grant
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
  • 批准号:
    10764456
  • 财政年份:
    2023
  • 资助金额:
    $ 17.72万
  • 项目类别:
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
  • 批准号:
    10715568
  • 财政年份:
    2023
  • 资助金额:
    $ 17.72万
  • 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
  • 批准号:
    10743328
  • 财政年份:
    2023
  • 资助金额:
    $ 17.72万
  • 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
  • 批准号:
    10638813
  • 财政年份:
    2023
  • 资助金额:
    $ 17.72万
  • 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
  • 批准号:
    10823828
  • 财政年份:
    2023
  • 资助金额:
    $ 17.72万
  • 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
  • 批准号:
    10828665
  • 财政年份:
    2023
  • 资助金额:
    $ 17.72万
  • 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
  • 批准号:
    10721095
  • 财政年份:
    2023
  • 资助金额:
    $ 17.72万
  • 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
  • 批准号:
    10795328
  • 财政年份:
    2023
  • 资助金额:
    $ 17.72万
  • 项目类别:
Mentoring Scientists for Careers in HIV Translational Clinical Research
指导科学家从事艾滋病毒转化临床研究
  • 批准号:
    10762827
  • 财政年份:
    2023
  • 资助金额:
    $ 17.72万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了